NORTHERN TRUST CORP - DIFFUSION PHARMACEUTICALS IN ownership

DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748305. A total of 26 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$50,000
-18.0%
200,9490.0%0.00%
Q4 2021$61,000
-40.2%
200,9490.0%0.00%
Q3 2021$102,000
-30.6%
200,9490.0%0.00%
Q2 2021$147,000
-20.1%
200,9490.0%0.00%
Q1 2021$184,000
+114.0%
200,949
+86.2%
0.00%
Q4 2020$86,000
-6.5%
107,894
-1.3%
0.00%
Q3 2020$92,000
-12.4%
109,306
+1.3%
0.00%
Q2 2020$105,000107,8940.00%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Yu Fan 269,544$213,0000.35%
Southland Equity Partners LLC 12,030$9,5640.01%
Sugarloaf Wealth Management, LLC 15,750$13,0000.00%
Frontier Wealth Management LLC 25,000$20,0000.00%
Renaissance Technologies 2,832,739$2,252,0000.00%
UBS Group AG 5,999$5,0000.00%
IFP Advisors, Inc 0$00.00%
Squarepoint Ops LLC 17,984$14,0000.00%
TWO SIGMA INVESTMENTS, LP 106,341$85,0000.00%
OSAIC HOLDINGS, INC. 29,477$24,0000.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders